Use of reperfusion therapy and cardiovascular drugs in the treatment of 146 men and 54 women with ST-segment elevation myocardial infarction at a University Medical Center.
We investigated the treatment of 146 men, mean age 62 years, and 54 women, mean age 69 years, with acute ST-segment elevation myocardial infarction (STEMI) in a university medical center. Coronary revascularization or thrombolytic therapy was given to 143 men (98%) and 52 women (96%) [P = not significant (NS)]. Antiplatelet therapy and antithrombotic therapy were given to 146 men (100%) and 54 women (100%) (P = NS). Beta-blockers were given to 133 men (91%) and 45 women (83%) (P = NS). Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers were given to 122 men (84%) and 42 women (78%) (P = NS). Statins were given to 128 men (88%) and 43 women (80%) (P = NS). Nitrates were given to 94 men (64%) and 36 women (67%) (P = NS). Diuretics were given to 97 men (66%) and 37 women (69%) (P = NS). Calcium channel blockers were given to 26 men (18%) and 12 women (22%) (P = NS). There was no significant difference in the treatment of men versus women with acute STEMI.
Sukhija
Rishi
R
Cardiology Division, Department of Medicine, Westchester Medical Center/New York Medical College, Valhalla, New York 10595, USA.
Aronow
Wilbert S
WS
Nayak
Devraj
D
McClung
John A
JA
Monsen
Craig E
CE
Belkin
Robert N
RN
D000368:Aged; D002317:Cardiovascular Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D048909:Diabetes Complications / Q000188:drug therapy; D004363:Drug Utilization; D005260:Female; D019983:Guideline Adherence; D006785:Hospitals, University; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000601:surgery*; D015425:Myocardial Reperfusion; D009204:Myocardial Revascularization; D017410:Practice Guidelines as Topic; D015912:Thrombolytic Therapy
D002317:Cardiovascular Agents